The Risk of Government Intrusion in Foreign Oil Stocks: China Petroleum & Chemical Corp (ADR) (SNP), Petroleo Brasileiro Petrobras SA (ADR) (PBR)

Page 1 of 2

The risk of governments meddling in the affairs of foreign-based oil companies is an important consideration. Harmful policies can quickly turn a highly profitable circumstance into a difficult, less lucrative operating environment. The recent deterioration of Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR) is a telling example.

Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR) is a Brazilian firm engaged in oil exploration, production, refining, and marketing. The company’s most appealing assets are its large oil and gas reserves. It has over 16 billion proven barrels of oil equivalent (BOE) mostly off the Brazilian coast. The company is also the major producer of fuel for Brazil’s growing economy.

Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR)Given these positives, one could expect increasing profits and a nice share price rise. Yet, the company’s adjusted cash earnings fell from around $12.1 billion in 2011 to $10.4 billion in 2012 and the stock price fell from a 52-week high of around $30 per share to a recent low below $15.

The main reason for this terrible performance has been government intrusion. The Brazilian government owns over 50% of Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR) and its influence has hampered operations. One example is the insistence that a substantial portion of necessary drilling equipment be Brazilian made. As the country’s suppliers are without the capacity to produce what’s needed, this edict has forced the company to endure unexpected delays, reduced oil production and increased cost.

Governmental legislation has hurt profitability even more. The country’s politicians mandate low retail fuel prices for societal reasons. Because Petrobras’ selling price is much lower than the price it has to pay to produce the fuel; the company loses money in its refining business. These losses totaled about $5.3 billion in 2011, with the deficit jumping to $12.6 billion in 2012.

Valuing a company, basically multiplying expected average cash earnings by a discounting capitalization factor, in such a situation is very difficult. If Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR) was an American firm, with the same superb oil & gas reserves and refining market share, it would probably deserve a higher capitalization multiple than the 8x industry average.

A 10x multiple might be reasonable given the company’s potential but with its history of government intervention, that would need to be reduced. For example, if one assumes a less restrictive government agenda, the company’s fair value looks to be around $17 a share based on earnings of $12.2 billion with a 9x multiple. But a more intrusive scenario results in earnings of $10 billion and an 8x multiple which drops the estimated reasonable business value closer to $10 per share.

Petrobras’ predicament is not unique. China Petroleum & Chemical Corp (ADR) (NYSE:SNP), otherwise known as Sinopec Shanghai Petrochemical Co. (ADR) (NYSE:SHI), faces many of the same issues. Sinopec engages in oil exploration, but its main business is refining. It is the largest refiner in Asia by annual volume and makes 60% more product per year than its nearest Chinese rival.

Sinopec is also hurt by government control over refined product pricing. The company’s adjusted earnings fell roughly 22% in the first half of 2012 mainly due to fuel subsidy policies. Sinopec also faces increasing costs due to a recent government dictate: Chinese energy firms are now expected to help solve the country’s massive pollution problem and Sinopec said it will need to spend about $4.8 billion a year to produce cleaner fuel.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!